In the event of a serious adverse reaction likely to be due to a tattooing product, the persons responsible for placing a tattooing product on the market, the health professionals who have observed it or the persons carrying out tattoos in a professional capacity who have knowledge of it shall report it without delay to the Director General of the Agence nationale de sécurité du médicament et des produits de santé.
These persons shall also report any other adverse reactions of which they are aware.
The health professional and persons who carry out tattoos on a professional basis shall specify whether the adverse reaction is the result of misuse and describe the conditions under which the tattoo was carried out.
Consumers may report any adverse reaction to the Agence nationale de sécurité du médicament et des produits de santé (French National Agency for the Safety of Medicines and Health Products), mentioning any misuse and describing the conditions under which the tattooing was carried out.
The reporting model is established by the Agence nationale de sécurité du médicament et des produits de santé.